Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Dodge & Cox

Dodge & Cox Balanced Fund Class I (DODBX)

Ticker DODBX · · Holdings as of Jun 30, 2026

Expense ratio
0.52%$52/yr per $10k
5-yr return
+9.4%annualized
1-yr return
+14.5%as of Dec 2025
Net assets
$14.7Ball share classes
Holdings
534

Bottom line

Is DODBX a good fund? The bottom line

DODBX is the Class I share class of Dodge & Cox Balanced Fund, a managed allocation / balanced mutual fund from Dodge & Cox.

Its expense ratio is 0.52% — about $52 a year on every $10,000 invested, cheaper than 86% of allocation / balanced funds we track.

It returned +14.5% over one year, +9.4% a year over five years, +9.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $14.7 billion in net assets and 534 holdings, its largest position is CVS Health Corp. (2.3%) and the top 10 make up 16.9% of the portfolio.

What stands out

  • Low cost: cheaper than 86% of allocation / balanced peers
  • 5-year return beat 94% of category peers
  • Broadly diversified (534 holdings)
  • No front-end sales load
  • Large and established ($14.7 billion)

Updated Nov 19, 2026

What DODBX invests in

The Fund seeks income and long-term capital appreciation.

The Fund invests in a diversified portfolio of equity securities and debt securities. Under normal circumstances no less than 25% and no more than 75% of the Funds total assets will be invested in equity securities and no less than 25% of the Funds total assets will be invested in fixed income investments. The Fund may invest up to 30% of its total assets in equity or debt securities of non-U.S. issuers that are not in the S&P 500 Index, including emerging market issuers; provided that no more than 10% of the Funds total assets may be invested in non-U.S. dollar-denominated securities. Investments in non-U.S. issuers may be made indirectly by investing in another Fund managed by Dodge & Cox. Asset allocation between equity and debt securities is based on Dodge & Coxs assessment of the potential risks and returns for each asset class over a three- to five-year horizon. Factors used to…

From the fund's prospectus (filed Apr 22, 2026).

DODBX performance

Fund calendar-year total returns, 2016–2025 2016: +16.6%; 2017: +12.6%; 2018: −4.6%; 2019: +19.6%; 2020: +7.9%; 2021: +19.3%; 2022: −7.3%; 2023: +13.8%; 2024: +8.8%; 2025: +14.5% +17% 2016 +13% 2017 −5% 2018 +20% 2019 +8% 2020 +19% 2021 −7% 2022 +14% 2023 +9% 2024 +14% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
DODBX+14.5%+9.4%+9.7%
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full DODBX performance history →

What DODBX costs

On a $10,000 investment, DODBX's 0.52% expense ratio costs about $52 a year. The prospectus estimates $664 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full DODBX fee table →

DODBX top 10 holdings

#Holding% of fund
1CVS Health Corp. CVS2.27%
2Taiwan Semiconductor Manufacturing Co., Ltd.2.18%
3Dodge & Cox Emerging Markets Stock Fund DODEX2.17%
4The Charles Schwab Corp. SCHW2.09%
5Humana, Inc. HUM1.56%
6Alphabet, Inc. GOOG1.53%
7RTX Corp. RTX1.38%
8Gsk Plc GSK1.28%
9Microsoft Corp. MSFT1.20%
10U.S. Treasury Inflation Indexed1.19%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 16.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to DODBX

More funds like DODBX →

DODBX FAQ

What is the expense ratio of DODBX?
DODBX's expense ratio is 0.52%, which works out to about $52 a year for every $10,000 invested. The prospectus estimates total costs of $664 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DODBX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 86% of allocation / balanced peers; 5-year return beat 94% of category peers; broadly diversified (534 holdings); no front-end sales load; large and established ($14.7 billion). This is general information, not personalized advice.
What does DODBX hold?
DODBX's largest holdings are CVS Health Corp. (2.3%), Taiwan Semiconductor Manufacturing Co., Ltd. (2.2%), Dodge & Cox Emerging Markets Stock Fund (2.2%), The Charles Schwab Corp. (2.1%), Humana, Inc. (1.6%). It holds 534 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is DODBX's 5-year return?
DODBX returned +9.4% a year over the five years ending Dec 31, 2025, and +9.7% a year over ten years. Past performance does not guarantee future results.
Does DODBX have a sales load?
No. DODBX has no front-end sales charge.
Who manages DODBX?
DODBX is offered by Dodge & Cox through Dodge & Cox Funds.